Cargando…

Patient perceptions of health-related quality of life in giant cell arteritis: international development of a disease-specific patient-reported outcome measure

OBJECTIVES: GCA is a large vessel vasculitis (LVV) presenting with headache, jaw claudication, musculoskeletal and visual involvement. Current treatment is glucocorticoids and anti-IL-6 tocilizumab in refractory disease. The objective of this study was to explore the impact of GCA and its treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robson, Joanna C, Almeida, Celia, Dawson, Jill, Bromhead, Alison, Dures, Emma, Guly, Catherine, Hoon, Elizabeth, Mackie, Sarah, Ndosi, Mwidimi, Pauling, John, Hill, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487303/ https://www.ncbi.nlm.nih.gov/pubmed/33528002 http://dx.doi.org/10.1093/rheumatology/keab076

Ejemplares similares

Comment on: Benchmarking tocilizumab use for giant cell arteritis
por: Janagan, Shalini, et al.
Publicado: (2022)

Factors associated with patient activation in inflammatory arthritis: a multisite cross-sectional study
por: Jones, Bethan, et al.
Publicado: (2021)

Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure
por: Bridgewater, Susan, et al.
Publicado: (2023)

Psychological and self-management support for people with vasculitis or connective tissue diseases: UK health professionals’ perspectives
por: Robson, Joanna C, et al.
Publicado: (2020)

Benchmarking tocilizumab use for giant cell arteritis
por: Conway, Richard, et al.
Publicado: (2022)

A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon, Elizabeth, et al.
Publicado: (2019)

Brief intervention to reduce fatigue impact in patients with inflammatory arthritis: design and outcomes of a single-arm feasibility study
por: Dures, Emma, et al.
Publicado: (2022)

Patient Reported Outcomes in Large Vessel Vasculitides
por: Robson, Joanna, et al.
Publicado: (2021)

Diagnosing and treating rheumatic and musculoskeletal diseases in low resource settings: a review of the challenges and opportunities in Tanzania
por: Furia, Francis, et al.
Publicado: (2023)

Diagnosis of giant cell arteritis by temporal artery biopsy is associated with biopsy length
por: Ruediger, Carlee, et al.
Publicado: (2022)

Incidence of giant cell arteritis is associated with COVID-19 prevalence: A population-level retrospective study
por: Mulhearn, Ben, et al.
Publicado: (2023)

What is the impact of giant cell arteritis on patients’ lives? A UK qualitative study
por: Liddle, Jennifer, et al.
Publicado: (2017)

Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
por: Esperança Almeida, Diogo, et al.
Publicado: (2023)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Measuring educational needs among patients with rheumatoid arthritis using the Dutch version of the Educational Needs Assessment Tool (DENAT)
por: Meesters, Jorit J. L., et al.
Publicado: (2009)

Measuring educational needs among patients with rheumatoid arthritis using the Dutch version of the Educational Needs Assessment Tool (DENAT)
por: Meesters, Jorit J. L., et al.
Publicado: (2009)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Increased number of cases of giant cell arteritis and higher rates of ophthalmic involvement during the era of COVID-19
por: Luther, Rosamond, et al.
Publicado: (2020)

Advantages in diagnosis of giant cell arteritis by ultrasound
por: Wojczal, Joanna, et al.
Publicado: (2019)

Foreword from the judges
por: Tan, Ai Lyn, et al.
Publicado: (2021)

Foreword from the judges
por: Tan, Ai Lyn, et al.
Publicado: (2023)

Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective
por: Mackie, Sarah L, et al.
Publicado: (2021)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Tuberculosis Infection in Chinese Patients with Giant Cell Arteritis
por: Zhang, Yun, et al.
Publicado: (2019)

Abdominal Pain in a Patient With Giant Cell Arteritis
por: Sundararajan, Tharani, et al.
Publicado: (2022)

Diagnostic delay for giant cell arteritis – a systematic review and meta-analysis
por: Prior, James A., et al.
Publicado: (2017)

Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis
por: Yoshida, Shuhei, et al.
Publicado: (2023)

No Association between FCγR3B Copy Number Variation and Susceptibility to Biopsy-Proven Giant Cell Arteritis
por: Dunstan, Emma, et al.
Publicado: (2013)

The effectiveness of e-learning in patient education delivered to patients with rheumatoid arthritis: The WebRA study—protocol for a pragmatic randomised controlled trial
por: Raunsbæk Knudsen, Line, et al.
Publicado: (2021)

A randomised, controlled study of outcome and cost effectiveness for RA patients attending nurse-led rheumatology clinics: Study protocol of an ongoing nationwide multi-centre study
por: Ndosi, Mwidimi, et al.
Publicado: (2011)

Association between glucocorticoid therapy and incidence of diabetes mellitus in polymyalgia rheumatica and giant cell arteritis: a systematic review and meta-analysis
por: Lai, Lana Yin Hui, et al.
Publicado: (2018)

Vision loss in patients with giant cell arteritis treated with tocilizumab
por: Amsler, Jennifer, et al.
Publicado: (2021)

Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients
por: Ramon, André, et al.
Publicado: (2022)

Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
por: Molina-Collada, Juan, et al.
Publicado: (2023)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nu4719lj2b7irji6c5d5ia4o5q